Gemfibrozil
A lipid-regulating agent that lowers elevated serum lipids primarily by decreasing serum triglycerides with a variable reduction in total cholesterol.
Year introduced: 1989
PubMed search builder options
Subheadings:
Tree Number(s): D02.241.081.114.968.500.750, D02.241.081.944.509.350, D02.355.726.305.750, D02.455.426.559.389.657.654.305.750, D10.251.400.895.593.350
MeSH Unique ID: D015248
Registry Number: Q8X02027X3
Entry Terms:
- Gemfibrosil
- Lopid
- Lopid R
- Lipur
- CI-719
- CI719
- CI 719
- Apo-Gemfibrozil
- ApoGemfibrozil
- Apo Gemfibrozil
- Ausgem
- Bolutol
- Chem mart Gemfibrozil
- DBL Gemfibrozil
- Decrelip
- Gemfi 1A Pharma
- Gemfibrozilo Bayvit
- Bayvit, Gemfibrozilo
- Gemfibrozilo Bexal
- Gemfibrozilo Ur
- Gemhexal
- Gen-Gemfibrozil
- GenGemfibrozil
- Gen Gemfibrozil
- GenRX Gemfibrozil
- Gemfibrozil, GenRX
- Healthsense Gemfibrozil
- Gemfibrozil, Healthsense
- Jezil
- Lipazil
- Lipox Gemfi
- Litarek
- Novo-Gemfibrozil
- Novo Gemfibrozil
- Nu-Gemfibrozil
- NuGemfibrozil
- Nu Gemfibrozil
- Pilder
- PMS-Gemfibrozil
- PMS Gemfibrozil
- SBPA Gemfibrozil
- Gemfibrozil, SBPA
- Terry White Chemists Gemfibrozil
- Trialmin
Previous Indexing:
Pharmacologic Action: